<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03402698</url>
  </required_header>
  <id_info>
    <org_study_id>meltiki D/09/2017</org_study_id>
    <nct_id>NCT03402698</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation in Children</brief_title>
  <acronym>MeltD</acronym>
  <official_title>Effectiveness of Vitamin D Supplementation in the Prevention of Vitamin D Deficiency in Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Memorial Health Institute, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nutropharma Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Memorial Health Institute, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prevalence of vitamin D deficiency in children in the northern country during winter season
      is very high (up to 90%). Vitamin D supplementation at a dose 600 -1000 IU/d is recommended
      in Polish children from September till April. However, there is shortage of studies in Polish
      children. The aim of the study is to assess the effectiveness of vitamin D supplementation in
      the prevention of vitamin D deficiency in Polish children (4-10 years of age).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prevalence of vitamin D deficiency in children in the northern country during winter season
      is very high (up to 90%). Vitamin D supplementation at a dose 600 -1000 IU/d is recommended
      in Polish children from September till April. However, there is shortage of studies in Polish
      children.

      Aims:

        1. Assessment of the impact of vitamin D intake at a dose of 1000 IU / day on vitamin D
           status in children aged 4-10 years.

        2. Evaluation of the effectiveness of supply of vitamin D at a dose of 1000 IU / day in
           preventing vitamin D deficiency and maintaining optimal vitamin D status ( 25OHD level
           &gt;30ng/ml)

        3. Evaluation of vitamin D status depending on age, BMI and body composition.

        4. Assessing the safety and tolerability of mel ● tiki vitamin D in children. Material:
           Children aged 4-10 years Study desing: Prospective intervention trial Intervention:
           cholecalciferol at a dose 1000 IU/day for 3 months

      Methods:

        1. Analysis of clinical characteristics (attendance at kindergarten / school, consumption
           of products rich in vitamin D, exposure to sun, use of sunblock's, the overall child's
           health (chronic diseases, medications, vitamins, micronutrients)

        2. Anthropometric measurements (body weight, height, BMI, assessment of body fat content -
           body composition by bioimpedance method- TANITA)

        3. Assessment of vitamin D status (serum total 25OHD concentration in blood serum by
           immunochemiluminescence method)

        4. Collecting data on the tolerability and safety of meliki ● tiki vitamin D including
           possible symptoms of vitamin D overdose
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum 25-hydroxyvitamin D level</measure>
    <time_frame>during 3 months of vitamin D supplementation</time_frame>
    <description>after intervension vs baseline level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prevalence of vitamin D deficiency</measure>
    <time_frame>during 3 months of vitamin D supplementation</time_frame>
    <description>serum 25-hydroxyvitamin D level &lt; 20ng/ml (after intervension vs baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prevalence of vitamin D suficiency</measure>
    <time_frame>during 3 months of vitamin D supplementation</time_frame>
    <description>serum 25-hydroxyvitamin D level &gt; 30ng/ml (after intervension vs baseline)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>cholecalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cholecalciferol at a dose 1000 IU /day for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>cholecalciferol</intervention_name>
    <description>supplementation at a dose 1000 IU/d</description>
    <arm_group_label>cholecalciferol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 4-10 years; declaration of no use other preparations containing vitamin D;
             parental written informed consent

        Exclusion Criteria:

          -  Osteoporosis, autoimmunological disorders, sarcoidosis, exacerbation of asthma,
             hypercalcemia, nephrolithiasis, renal insufficiency, nephrotic syndrome, cholestasis,
             hepatitis, diabetes typ 1, anticonvulsant treatment, prolonged treatment with
             steroids, cimetidine, ketoconazole, teophiline, diuretics, anti-tuberculosis drugs,
             participation in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justyna Czech-Kowalska</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Children's Memorial Health Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Justyna Czech-Kowalska</last_name>
    <phone>228157770</phone>
    <phone_ext>+48</phone_ext>
    <email>j.kowalska@ipczd.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Children's Memorial Health Institute</name>
      <address>
        <city>Warsaw</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justyna Czech-Kowalska, MD, PhD</last_name>
      <phone>228157770</phone>
      <phone_ext>+48</phone_ext>
      <email>j.kowalska@ipczd.pl</email>
    </contact>
    <investigator>
      <last_name>Justyna Czech-Kowalska, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2018</study_first_submitted>
  <study_first_submitted_qc>January 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2018</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Memorial Health Institute, Poland</investigator_affiliation>
    <investigator_full_name>Justyna Czech-Kowalska, Associate Professor</investigator_full_name>
    <investigator_title>Deputy Head of Neonatal Department</investigator_title>
  </responsible_party>
  <keyword>cholecalciferol</keyword>
  <keyword>BMI</keyword>
  <keyword>winter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

